RA Capital Management’s Alpine Immune Sciences, Inc. Common Stock ALPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,909,763
| Closed | -$93.6M | – | 79 |
|
|
2023
Q4 | $93.6M | Buy |
4,909,763
+218,585
| +5% | +$4.17M | 1.46% | 19 |
|
|
2023
Q3 | $53.7M | Hold |
4,691,178
| – | – | 1.06% | 27 |
|
|
2023
Q2 | $48.2M | Buy |
4,691,178
+3,063
| +0.1% | +$31.5K | 0.91% | 31 |
|
|
2023
Q1 | $36.2M | Buy |
4,688,115
+290,747
| +7% | +$2.24M | 0.82% | 37 |
|
|
2022
Q4 | $32.3M | Buy |
4,397,368
+40,736
| +0.9% | +$299K | 0.66% | 38 |
|
|
2022
Q3 | $31.4M | Buy |
+4,356,632
| New | +$31.4M | 0.67% | 45 |
|
|
2016
Q2 | – | Sell |
-153,216
| Closed | -$2.56M | – | 38 |
|
|
2016
Q1 | $2.56M | Hold |
153,216
| – | – | 0.33% | 38 |
|
|
2015
Q4 | $4.74M | Hold |
153,216
| – | – | 0.47% | 32 |
|
|
2015
Q3 | $7.95M | Sell |
153,216
-36,100
| -19% | -$1.87M | 1.14% | 29 |
|
|
2015
Q2 | $11.5M | Buy |
+189,316
| New | +$11.5M | 1.15% | 27 |
|